Susan Kantor - Sep 29, 2023 Form 4 Insider Report for Envoy Medical, Inc. (ANZU)

Role: Director
Signature: /s/ Andrew P. Campbell as attorney-in-fact for Susan J. Kantor
Stock symbol: ANZU
Transactions as of: Sep 29, 2023
Transactions value $: $0
Form type: 4
Date filed: 10/3/2023, 09:50 PM
Next filing: Oct 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANZU	Class A Common Stock, par value $0.0001 per share	Conversion of derivative security		+25K			25K	Sep 29, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANZU	Class B Common Stock, par value $0.0001 per share	Conversion of derivative security	$0	-25K	-100%	$0.00^*	0	Sep 29, 2023	Class A Common Stock, par value $0.0001 per share	25K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On September 29, 2023, in connection with the consummation of the business combination between Anzu Special Acquisition Corp I and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share.